Krystal Biotech Appoints Dr. Chris Mason and Dr. Jing Marantz to its Board of Directors

Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases today announced the appointment of Chris Mason, MD, PhD, FRCS, FMedSci, and Jing L. Marantz, …
( read original story …)